Honu

Honu Therapeutics is an early-stage biotechnology company based in San Diego, California, dedicated to developing transformative treatments for metabolic disorders, with a primary focus on obesity and type 2 diabetes. Founded by Dr. Alexander "Sasha" Kamb, a former Senior Vice President of Discovery Research at Amgen, the company leverages deep insights into human genetics and physiology to identify high-impact therapeutic targets. Honu Therapeutics utilizes a data-driven discovery engine to validate novel pathways that regulate energy balance and glucose metabolism. Backed by prominent life science investors such as ARCH Venture Partners, the company is currently advancing its pipeline through pre-clinical development. Its mission is to address the global metabolic health crisis by providing innovative pharmacological interventions that offer superior efficacy and safety profiles.